
Gilbert Ray Cisneros Jr.
DHouseRepresentative · California
Bought up to $15,000 of Bridgebio Pharma (BBIO)
Trade dated Mar 3, 202635 days to disclose
BBIO since the buy
+4.3%
S&P 500, same window
+11.3%
▼ BBIO trailed the S&P 500 by 6.9 points since the buy
Price move from the trade date's close to the most recent close. A buy is favorable when the stock rose after.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Dec 18, 2025Floor voteResult: Failed
- Dec 18, 2025Floor voteResult: Passed
- Feb 10, 2026LegislationPharmaceutical sector
- Feb 11, 2026LegislationPharmaceutical sector
- Mar 3, 2026LegislationPharmaceutical sector
- Mar 3, 2026TradeBought up to $15,000 of BBIO
- Mar 4, 2026LegislationPharmaceutical sector
- Mar 12, 2026LegislationPharmaceutical sector
- Apr 7, 2026DisclosureDisclosed the tradePublic filing
- Apr 16, 2026Floor voteResult: Passed
- Apr 21, 2026Floor voteResult: Passed
- Apr 27, 2026Floor voteResult: Passed
- May 15, 2026CommitteeDepartment of the Army Fiscal Year 2027 Budget Request
- May 19, 2026CommitteeU.S. Military Posture and National Security Challenges in the Greater Middle East and Africa
- May 20, 2026CommitteeDepartment of the Air Force Fiscal Year 2027 Budget Request
Get an alert the moment Gilbert Ray Cisneros Jr. files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.